Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
No injuries after blast at pro-Israel centre in the Netherlands - 2Make your choice for the PS5 game that you love playing with companions!
- 3Israel says it killed armed Hamas 'terrorists' in Gaza
- 4Satellites capture aftermath of Ethiopian volcano's 1st eruption in recorded history (images)
- 5Jubilant FoodWorks to scrap Dunkin’ franchise arrangement in India
- Which game do you cherish observing live? Vote!
- Two policemen injured at religious youth protest in Jerusalem marking Ahuvia Sandak's death
- As reefs vanish, assisted coral fertilization offers hope in the Dominican Republic
- Israeli Chief of Staff declares new border with Gaza Strip
- 6 Tire Brands Reasonable for Seniors
- 75% of US adults may meet criteria for obesity under new definition, study finds
- 'Wuthering Heights' trailer features Margot Robbie and Jacob Elordi in a steamy forbidden romance
- Consumer outlook on UK economy falls to two-year low
- 6 Vehicle Rental Administrations: Pick Your Ideal Ride
